Impact on cytoprotective efficacy of intermediate interval between amifostine administration and radiotherapy: a retrospective analysis

This publication has 21 references indexed in Scilit:

• Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2000
• Amifostine (Ethyol®): Dosing, administration and patient management guidelines
  European Journal of Cancer, 1996
• The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine (Ethyol®)
  European Journal of Cancer, 1996
• Pathophysiology of irradiated skin and breast
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995
• Use of radiation with or without WR-2721 in advanced rectal cancer
  Cancer, 1992
• Topical or Systemic 16,16 Dm Prostaglandin E₂or WR-2721 (WR-1065) Protects Mice from Alopecia after Fractionated Irradiation
  International Journal of Radiation Biology, 1992
• Interim analysis of a randomized trial of radiation therapy of rectal cancer with/without WR-2721
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1992
• Pharmacokinetics of WR-2721
  Pharmacology & Therapeutics, 1988
• Radioprotectors in tumor radiotherapy: factors and settings determining therapeutic ratio
  Pharmacology & Therapeutics, 1988
• Clinical trials of WR-2721 with radiation therapy
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1982